Form 4: Lyell Immunopharma Insider Sells Shares
Insider Transaction (Form 4)
Innovative Cellular Therapeutics Holdings Ltd reported changes in beneficial ownership of Lyell Immunopharma, Inc. common stock on July 16, 2026.
Summary
- Open-market sale: disposed of 10 Common Stock at $13.73 ($137) on July 16, 2026; holds 2,857,490 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $137 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Innovative Cellular Therapeutics Holdings Ltd — 10% owner
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-16 | Open-market sale | Common Stock | 10 | $14 | $137 | 2,857,490 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-16 | Open-market sale (10 shares) |
Keywords
insider transaction, Form 4, LYEL, Lyell Immunopharma, Inc., bearish, Innovative Cellular Therapeutics Holdings Ltd
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.